HMGB2 is a negative regulator of telomerase activity in human
embryonic stem and progenitor cells

J 2019

HMGB2 is a negative regulator of telomerase activity in human embryonic stem and progenitor cells

KUČÍREK, Martin, Alireza Jian BAGHERPOOR, Josef JAROŠ, Aleš HAMPL, Michal ŠTROS et. al.

Základní údaje

Originální název

HMGB2 is a negative regulator of telomerase activity in human embryonic stem and progenitor cells

Autoři

KUČÍREK, Martin (203 Česká republika), Alireza Jian BAGHERPOOR (203 Česká republika), Josef JAROŠ (203 Česká republika, domácí), Aleš HAMPL (203 Česká republika, domácí) a Michal ŠTROS (203 Česká republika, garant)

Vydání

FASEB Journal, Federation of American Societies for Experimental Biology, 2019, 0892-6638

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

10608 Biochemistry and molecular biology

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 4.966

Kód RIV

RIV/00216224:14110/19:00108537

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1096/fj.201901465RRR

UT WoS

000507466100097

Klíčová slova anglicky

HMGB1; hESCs; neuroectodermal cells; telomeres

Štítky

14110517, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 11. 5. 2020 10:16, Mgr. Tereza Miškechová

Anotace

V originále

High-mobility group box (HMGB)1 and HMGB2 proteins are the subject of intensive research because of their involvement in DNA replication, repair, transcription, differentiation, proliferation, cell signaling, inflammation, and tumor migration. Using inducible, stably transfected human embryonic stem cells (hESCs) capable of the short hairpin RNA-mediated knockdown (KD) of HMGB1 and HMGB2, we provide evidence that deregulation of HMGB1 or HMGB2 expression in hESCs and their differentiated derivatives (neuroectodermal cells) results in distinct modulation of telomere homeostasis. Whereas HMGB1 enhances telomerase activity, HMGB2 acts as a negative regulator of telomerase activity in the cell. Stimulation of telomerase activity in the HMGB2-deficient cells may be related to activation of the PI3K/protein kinase B/ glycogen synthase kinase-313/ I3-catenin signaling pathways by HMGB1, augmented TERT/telomerase RNA subunit transcription, and possibly also because of changes in telomeric repeat-containing RNA (TERRA) and TERRA-polyA(+) transcription. The impact of HMGB1/2 KD on telomerase transcriptional regulation observed in neuroectodermal cells is partially masked in hESCs by their pluripotent state. Our findings on differential roles of HMGB1 and HMGB2 proteins in regulation of telomerase activity may suggest another possible outcome of HMGB1 targeting in cells, which is currently a promising approach aiming at increasing the anticancer activity of cytotoxic agents.

Návaznosti

MUNI/A/1565/2018, interní kód MU

Název: Zdroje pro tkáňové inženýrství 9 (Akronym: TissueEng 9)

Investor: Masarykova univerzita, Zdroje pro tkáňové inženýrství 9, DO R. 2020_Kategorie A - Specifický výzkum - Studentské výzkumné projekty

NV16-31501A, projekt VaV

Název: Tkáňové inženýrství epitelů: Buňky a protokoly pro regenerativní medicínu

Citovat

KUČÍREK, Martin, Alireza Jian BAGHERPOOR, Josef JAROŠ, Aleš HAMPL a Michal ŠTROS. HMGB2 is a negative regulator of telomerase activity in human embryonic stem and progenitor cells. FASEB Journal. Federation of American Societies for Experimental Biology, 2019, roč. 33, č. 12, s. 14307-14324. ISSN 0892-6638. Dostupné z: https://dx.doi.org/10.1096/fj.201901465RRR.

@article{1577476,
   author = {Kučírek, Martin and Bagherpoor, Alireza Jian and Jaroš, Josef and Hampl, Aleš and Štros, Michal},
   article_number = {12},
   doi = {http://dx.doi.org/10.1096/fj.201901465RRR},
   keywords = {HMGB1; hESCs; neuroectodermal cells; telomeres},
   language = {eng},
   issn = {0892-6638},
   journal = {FASEB Journal},
   title = {HMGB2 is a negative regulator of telomerase activity in human embryonic stem and progenitor cells},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/31661640},
   volume = {33},
   year = {2019}
}

TY  - JOUR
ID  - 1577476
AU  - Kučírek, Martin - Bagherpoor, Alireza Jian - Jaroš, Josef - Hampl, Aleš - Štros, Michal
PY  - 2019
TI  - HMGB2 is a negative regulator of telomerase activity in human embryonic stem and progenitor cells
JF  - FASEB Journal
VL  - 33
IS  - 12
SP  - 14307-14324
EP  - 14307-14324
PB  - Federation of American Societies for Experimental Biology
SN  - 08926638
KW  - HMGB1
KW  - hESCs
KW  - neuroectodermal cells
KW  - telomeres
UR  - https://www.ncbi.nlm.nih.gov/pubmed/31661640
L2  - https://www.ncbi.nlm.nih.gov/pubmed/31661640
N2  - High-mobility group box (HMGB)1 and HMGB2 proteins are the subject of intensive research because of their involvement in DNA replication, repair, transcription, differentiation, proliferation, cell signaling, inflammation, and tumor migration. Using inducible, stably transfected human embryonic stem cells (hESCs) capable of the short hairpin RNA-mediated knockdown (KD) of HMGB1 and HMGB2, we provide evidence that deregulation of HMGB1 or HMGB2 expression in hESCs and their differentiated derivatives (neuroectodermal cells) results in distinct modulation of telomere homeostasis. Whereas HMGB1 enhances telomerase activity, HMGB2 acts as a negative regulator of telomerase activity in the cell. Stimulation of telomerase activity in the HMGB2-deficient cells may be related to activation of the PI3K/protein kinase B/ glycogen synthase kinase-313/ I3-catenin signaling pathways by HMGB1, augmented TERT/telomerase RNA subunit transcription, and possibly also because of changes in telomeric repeat-containing RNA (TERRA) and TERRA-polyA(+) transcription. The impact of HMGB1/2 KD on telomerase transcriptional regulation observed in neuroectodermal cells is partially masked in hESCs by their pluripotent state. Our findings on differential roles of HMGB1 and HMGB2 proteins in regulation of telomerase activity may suggest another possible outcome of HMGB1 targeting in cells, which is currently a promising approach aiming at increasing the anticancer activity of cytotoxic agents.
ER  -

KUČÍREK, Martin, Alireza Jian BAGHERPOOR, Josef JAROŠ, Aleš HAMPL a Michal ŠTROS. HMGB2 is a negative regulator of telomerase activity in human embryonic stem and progenitor cells. \textit{FASEB Journal}. Federation of American Societies for Experimental Biology, 2019, roč.~33, č.~12, s.~14307-14324. ISSN~0892-6638. Dostupné z: https://dx.doi.org/10.1096/fj.201901465RRR.

Podrobný výpis o publikaci